Results of a clinical trial show that administering stem cells to patients derived from their own bone marrow either three or seven days after a heart attack is safe but does not improve heart function six months later. The results of the trial, called Transplantation In Myocardial Infarction Evaluation (TIME), mirror a previous, related study, LateTIME, which found that such cells (called autologous stem cells) given two to three weeks after a heart attack did ...
via Medindia Health News
More READ
No comments:
Post a Comment